finance.foundation / Companies / ABBV vs ABT
Comparison · seed-0.6 · 2026-08-29
AbbVie (ABBV) vs Abbott (ABT)
AbbVie (ABBV) and Abbott (ABT) side by side: both in Healthcare, both listed on New York Stock Exchange. AbbVie is the larger of the two by approximate market capitalization (about 1.7×).
| Field | AbbVie | Abbott |
|---|---|---|
| Legal name | AbbVie Inc. | Abbott Laboratories |
| Ticker | ABBV | ABT |
| Exchange | New York Stock Exchange XNYS | New York Stock Exchange XNYS |
| Jurisdiction | United States | United States |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceuticals | Medical devices & diagnostics |
| Market cap ≈ | $390bn | $230bn |
| Founded | 2013 | 1888 |
| Reporting currency | USD | USD |
| LEI | FR5LCKFTG8054YNNRU85 | 549300I73MX1K4BJJV80 |
| ISIN | US00287Y1091 | US0028241000 |
| FIGI | BBG0025Y4RZ3 | BBG001S5N9M6 |
| Index membership | S&P 500 | S&P 500 |
| Held by (covered funds) | — | — |
AbbVie
Large pharmaceutical company spun off from Abbott in 2013, with immunology blockbusters Skyrizi and Rinvoq succeeding Humira, plus the Allergan aesthetics portfolio (Botox).
Abbott
Diversified healthcare company spanning medical devices (FreeStyle Libre glucose monitors), diagnostics, nutrition brands like Ensure, and established pharmaceuticals.
What they share
Same indices: S&P 500
Approximate reference values (seed-0.6 · 2026-08-29) — not real-time, not investment advice. Both sides as data: /api/v1/companies/abbvie · /api/v1/companies/abbott